Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Research output: Contribution to journalReviewResearchpeer-review

  1. ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The risk of late effects following pediatric and adult radiotherapy regimens in Hodgkin lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.

Original languageEnglish
JournalInternational Journal of Radiation Oncology Biology Physics
Volume102
Issue number3
Pages (from-to)508-514
Number of pages7
ISSN0360-3016
DOIs
Publication statusPublished - 1 Nov 2018

ID: 55856737